From PBS NewsHour.

The Food and Drug Administration has reversed course and will now consider whether to approve a new flu shot from Moderna that uses mRNA technology.

The new development comes a week after the FDA rejected the company’s initial application, saying its research design was flawed.

Moderna is now seeking full approval for the vaccine’s use in adults aged 50 to 64 and what’s called accelerated approval for those 65 and older.

The company says the FDA set an August deadline for approval. Moderna hopes to make the vaccine available later this year.

Watch PBS News for daily, breaking and live news, plus special coverage. We are home to PBS News Hour, ranked the most credible and objective TV news show.

Sign up for Here’s The Deal with Lisa Desjardins: https://to.pbs.org/41q6E8i
Subscribe for exclusive content in our newsletters: https://www.pbs.org/newshour/subscribe
PBS News podcasts: https://www.pbs.org/newshour/podcasts
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS News at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
TikTok: https://www.tiktok.com/@pbsnews
X: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Facebook: http://www.pbs.org/newshour